BH3 peptides and methods of use thereof
The invention provides peptides and the nucleic acid sequences that encode them. The invention further provides therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of apoptosis associated disorders.
1. A composition for detecting homo-oligomerization of a BAX or a BAK protein in a mitochondrial membrane comprising a synthetic or recombinant BH3 peptide comprising SEQ ID NO: 2 , and a mitochondrion comprising a BAX or a BAK protein and overexpressing a BCL-2 or BCL-XL protein, wherein the BH3 peptide is less than or equal to 50 amino acids in length, and wherein the BH3 peptide forms a complex with BCL-2 or BCL-XL protein resident on the mitochondrion and activates pro-apoptotic BAX or BAK when displaced from the complex to thereby induce homo-oligomerization of the BAX or the BAK protein in the mitochondrial membrane.
2. The composition of claim 1 , wherein the mitochondrion is isolated from a cell.
3. The composition of claim 1 , wherein the BH3 peptide is less than or equal to 35 amino acids in length.
4. The composition of claim 1 , wherein the BH3 peptide is less than or equal to 25 amino acids in length.
5. A composition for detecting homo-oligomerization of a BAX or a BAK protein in a mitochondrial membrane comprising a mitochondrion contacted with a synthetic or recombinant BH3 peptide comprising SEQ ID NO: 2, wherein the mitochondrion comprises a BAX or a BAK protein and overexpresses a BCL-2 or BCL-XL protein, and wherein the BH3 peptide is less than or equal to 50 amino acids in length, and wherein the BH3 peptide forms a complex with BCL-2 or BCL-XL protein resident on the mitochondrion and activates pro-apoptotic BAX or BAK when displaced from the complex to thereby induce homo-oligomerization of the BAX or the BAK protein in the mitochondrial membrane.
6. The composition of claim 5 , wherein the mitochondrion is isolated from a cell.
7. The composition of claim 5 , wherein the BH3 peptide is less than or equal to 35 amino acids in length.
8. The composition of claim 5 , wherein the BH3 peptide is less than or equal to 25 amino acids in length.